Aardvark Therapeutics, Inc. Common Stock (AARD) earnings · $284.4M cap
These earnings events as JSON? API free 100/dayAardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
This AARD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
When the next AARD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AARD research stays on the stock page; the tape stays on the quote page.
AARD earnings FAQ
What is AARD's latest net income?
Latest cached Aardvark Therapeutics, Inc. Common Stock (AARD) net income was -$57.6M. Statements: https://lician.com/financials/aard
What is AARD's latest diluted EPS?
Latest cached Aardvark Therapeutics, Inc. Common Stock (AARD) diluted EPS for Dec 31, 2025 was -$2.93.
What period does the latest AARD earnings print cover?
The latest cached Aardvark Therapeutics, Inc. Common Stock (AARD) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are AARD earnings listed?
Cached earnings facts for Aardvark Therapeutics, Inc. Common Stock (AARD) are listed at https://lician.com/earnings/aard. Statements: https://lician.com/financials/aard
Not investment advice.